Table 3.

Antibacterial activity of nanomaterials combined with antibiotics.

Nanomaterials	Antibiotics	Target Bacteria	References
Ag NPs	Ciprofloxacin	VRE	[135]
	Vancomycin	MRSA	[136]
	Clotrimazole	MRSA, S. aureus	[137]
Au NPs	Vancomycin	MRSA	[138]
	Ampicillin	MRSA, P. aeruginosa, Enterobacter aerogenes, E. coli	[139]
ZnO NPs	Ciprofloxacin, ceftazidime	MDR A. baumannii	[140]
Fe3O4 NPs	Ampicillin	S. aureus	[141]
	Ampicillin	E. coli, P. aeruginosa, MRSA	[142]
CuO NPs	Cephalexin	E. coli	[143]
SWCNTs	Ciprofloxacin	S. aureus, P. aeruginosa, E. coli	[144]
GO	Lincomycin hydrochloride Chloramphenicol Gentamycin sulfate	E. coli, S. aureus	[134]
AMPs-NPs	Gentamicin, vancomycin, azithromycin, amoxicillin	E. coli, S. aureus, P. aeruginosa, A. baumannii	[145]
Chitosan	Streptomycin	Listeria monocytogenes	[146]
	Ciprofloxacin	Uropathogenic E. coli	[133]

SWCNTs, single-walled carbon nanotubes.